Literature DB >> 9247130

Using structure to define the function of phosphoinositide 3-kinase family members.

J Domin1, M D Waterfield.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9247130     DOI: 10.1016/s0014-5793(97)00617-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  55 in total

1.  Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network.

Authors:  A Kihara; Y Kabeya; Y Ohsumi; T Yoshimori
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

2.  Overexpression of a rat kinase-deficient phosphoinositide 3-kinase, Vps34p, inhibits cathepsin D maturation.

Authors:  P E Row; B J Reaves; J Domin; J P Luzio; H W Davidson
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

3.  Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.

Authors:  C A Beeton; E M Chance; L C Foukas; P R Shepherd
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

4.  Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Authors:  I Gout; G Middleton; J Adu; N N Ninkina; L B Drobot; V Filonenko; G Matsuka; A M Davies; M Waterfield; V L Buchman
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

5.  The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB.

Authors:  Z G Cui; N Y Hong; H K Kang; D H Lee; Y K Lee; D B Park
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

Review 6.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 7.  Phosphatidylinositol-3,4,5-triphosphate and cellular signaling: implications for obesity and diabetes.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Cell Physiol Biochem       Date:  2015-02-11

Review 8.  Inhibitors of phosphatidylinositol-3-kinase in cancer therapy.

Authors:  Nathan T Ihle; Garth Powis
Journal:  Mol Aspects Med       Date:  2010-02-20

Review 9.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

10.  Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Authors:  Frank Schönleben; Wanglong Qiu; John D Allendorf; John A Chabot; Helen E Remotti; Gloria H Su
Journal:  J Gastrointest Surg       Date:  2009-05-14       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.